Bayer: Diabetes Mellitus, Type 2 trials
The registry lists 37 Diabetes Mellitus, Type 2 studies with Bayer as lead sponsor. 3 are open to participants now and 4 have results posted.
Phase 1 4Phase 2 3Phase 3 3Phase 4 2No phase 25(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Learn More About How Well Finerenone Works in Real-world in People With Type 2 Diabetes and Chronic Kidney Disease in Primary Care (IMSS= Instituto Mexicano Del Seguro Social)Not yet recruitingNCT07841015
- An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CKD) Linked to Type 2 Diabetes, by Looking at Changes in a CKD Risk ScoreRecruitingNCT07554469
- An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world ConditionsRecruitingNCT06278207
- A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 DiabetesCompletedNCT05254002Phase 2Results posted
- An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD ParticipantsCompletedNCT05013008Phase 2Results posted
- Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney DiseaseCompletedNCT02545049Phase 3Results posted
- Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney DiseaseCompletedNCT02540993Phase 3Results posted
- An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South KoreaActive, not recruitingNCT07232537
- An Observational Study Called FIRST-2.0 China to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions in a Chinese Population.CompletedNCT07124039
- An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical PracticeActive, not recruitingNCT06763146
- An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United StatesCompletedNCT06608212
- A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 2 Diabetes MellitusCompletedNCT05705271Phase 4
- An Observational Study Called FIRST-2.0 to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world ConditionsCompletedNCT05703880
- An Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-term Kidney Disease (Chronic Kidney Disease) Together With Type 2 Diabetes by Using Routine Medical Care Data and Past Clinical Study ResultsCompletedNCT05640180
- A Study Called SMART-Finder to Look for People With Increased Amounts of Albumin in the Urine (UACR Level) in a Group of Type 2 Diabetes Mellitus PatientsCompletedNCT05552339
- An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical PracticeCompletedNCT05526157
- A Study Using Surveys to Learn More About Treatment With Steroidal Mineralocorticoid Receptor Antagonists, How They Are Used, What Side Effects They Have, and How Satisfied People Who Receive Them Are in the USCompletedNCT05407662
- A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care SettingActive, not recruitingNCT05348733
- A Study to Learn More About Chronic Kidney Disease (CKD) in Patients With Type 2 Diabetes Mellitus (T2DM)CompletedNCT05004428
- A Study to Learn More About How Acarbose and Metformin Work When Taken Together and How Safe They Are in Indian Patients Who Were Recently Diagnosed With Type 2 Diabetes (T2D)CompletedNCT04665570
- Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D)CompletedNCT04498156
- A Study Using the LMC Diabetes Registry to Learn More About Chronic Kidney Disease (CKD) in Canadian Patients With Type 2 Diabetes (T2D)CompletedNCT04445181
- Study to Learn More About Outcomes Reported by Patients Suffering From Type 2 Diabetes Using a Digital Data Collection ToolCompletedNCT04383041
- Bioequivalence Study for Acarbose/Metformin FDCCompletedNCT04065581Phase 1
- Study to Develop a Tool to Estimate the Kidney Function in Databases Without Laboratory DataCompletedNCT03605810
- A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY1142524 in Patients With Type II Diabetes and a Clinical Diagnosis of Diabetic Kidney DiseaseCompletedNCT03412006Phase 2
- Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure PatientsCompletedNCT03349684Phase 3
- Study to Assess the Dietary Carbohydrate Content of Indian Diabetics With Special Therapeutic View on Effectiveness of Acarbose and Metformin MonotherapyWithdrawnNCT01961388
- GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life PracticeWithdrawnNCT01915264
- Bioequivalence Study for Acarbose / Metformin FDCCompletedNCT01728740Phase 1
- Diabetes Treatment With Glucobay in Combination With SulfonylureaCompletedNCT01613105
- Diabetes Treatment With Glucobay in Combination With MetforminCompletedNCT01612741
- To Evaluate Clinical Outcome and Injection Compliance of ScilinCompletedNCT01588639
- A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mgCompletedNCT01554631Phase 1
- A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard TabletCompletedNCT01388153Phase 1
- GLucobay M OBservation Study for Efficacy and Safety in Treatment of Type-2 Diabetes PatientsCompletedNCT01219582
- Glucose Reduction by Early Acarbose Treatment in Basal InsulinCompletedNCT00970528Phase 4